672 The effect of chemoradiotherapy and tumor histology on the immune contexture of tumor-draining lymph nodes in NSCLC

672 The effect of chemoradiotherapy and tumor histology on the immune contexture of tumor-draining lymph nodes in NSCLC

Bibliographic Details
Main Authors:	Tanja de Gruijl, Teodora Radonic, Chris Dickhoff, Marieke Fransen, Famke Schneiders, Vinitha Kandiah, Idris Bahce
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial
by: Chris Dickhoff, et al.
Published: (2020-08-01)

Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
by: Marieke F. Fransen, et al.
Published: (2021-08-01)

Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC
by: Ezgi B. Ulas, BSc, et al.
Published: (2023-09-01)

Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes
by: Frank J. Borm, et al.
Published: (2023-12-01)

Immunotherapy Goes Local: The Central Role of Lymph Nodes in Driving Tumor Infiltration and Efficacy
by: Kim M. van Pul, et al.
Published: (2021-03-01)

Effects of Hyperthermia and Hyperthermic Intraperitoneal Chemoperfusion on the Peritoneal and Tumor Immune Contexture
by: Daryl K. A. Chia, et al.
Published: (2023-08-01)

The Singapore contexture.
by: Tok, Sing Ying.
Published: (2011)

Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
by: Francesca Finotello, et al.
Published: (2019-05-01)

Revealing the secret behind Epstein‐Barr virus‐specific tumor immune contexture
by: Chu‐Xia Deng
Published: (2024-04-01)

Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
by: Francesca Finotello, et al.
Published: (2019-07-01)

Early circulating tumor DNA dynamics at the commencement of curative-intent radiotherapy or chemoradiotherapy for NSCLC
by: Michael MacManus, et al.
Published: (2023-11-01)

Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture
by: Xin Liu, et al.
Published: (2020-01-01)

Long-Term Outcomes After Chemoradiotherapy and Surgery for Superior Sulcus Tumors
by: S. Ünal, BS, et al.
Published: (2023-04-01)

Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer
by: Sujun Han, et al.
Published: (2023-03-01)

Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer
by: Jhe‐Cyuan Guo, et al.
Published: (2023-08-01)

IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection
by: Karsten A. Pilones, et al.
Published: (2020-01-01)

Contextural knowledge and the diffusion of the technology in construction
by: Brach, Ann M. (Ann Margaret), 1962-
Published: (2005)

First exploration of the on-treatment changes in tumor and organ uptake of a radiolabeled anti PD-L1 antibody during chemoradiotherapy in patients with non-small cell lung cancer using whole body PET
by: Tanja D de Gruijl, et al.
Published: (2024-02-01)

Pharmacokinetics and pharmacodynamics of therapeutic antibodies in tumors and tumor-draining lymph nodes
by: Eric Salgado, et al.
Published: (2021-04-01)

State-of-the-Art of Profiling Immune Contexture in the Era of Multiplexed Staining and Digital Analysis to Study Paraffin Tumor Tissues
by: Edwin Roger Parra, et al.
Published: (2019-02-01)

Chemotherapy but Not the Tumor Draining Lymph Nodes Determine the Immunotherapy Response in Secondary Tumors
by: Xianda Zhao, et al.
Published: (2020-05-01)

The role of chemoradiotherapy and immunotherapy in stage III NSCLC
by: Zsuzsanna Orosz, et al.
Published: (2024-04-01)

The Immune Contexture of Liposarcoma and Its Clinical Implications
by: Antonia Resag, et al.
Published: (2022-09-01)

Data-Driven Discovery of Immune Contexture Biomarkers
by: Lars Ole Schwen, et al.
Published: (2018-12-01)

Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy
by: Li-Na He, et al.
Published: (2023-07-01)

Multimodal profiling of chordoma immunity reveals distinct immune contextures
by: Marieke E Ijsselsteijn, et al.
Published: (2024-01-01)

Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery
by: Alfons Navarro, et al.
Published: (2019-02-01)

Yeast-derived nanoparticles remodel the immunosuppressive microenvironment in tumor and tumor-draining lymph nodes to suppress tumor growth
by: Jialu Xu, et al.
Published: (2022-01-01)

Investigative contexture: scientific research in the human-social field
by: Latif Antônia Cassab
Published: (2007-05-01)

Coimmunomodulation of tumor and tumor-draining lymph nodes during in situ vaccination promotes antitumor immunity
by: Moonkyoung Jeong, et al.
Published: (2022-06-01)

Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer
by: Jonathan Khalifa, et al.
Published: (2023-11-01)

CD8+ T Lymphocyte Subsets in Bladder Tumor Draining Lymph Nodes
by: Zahra Faghih, et al.
Published: (2016-12-01)

2.672 Projects Laboratory, Spring 2004
by: Cheng, Wai Kong, et al.
Published: (2010)

Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix
by: Lucie Pavelková, et al.
Published: (2024-03-01)

Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis
by: Massimo Milione, et al.
Published: (2020-07-01)

Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy
by: Kazumi Okamura, et al.
Published: (2022-05-01)

Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma
by: Patrizia Gasparini, et al.
Published: (2019-09-01)

Focus on Nintedanib in NSCLC and other tumors
by: Anna Manzo, et al.
Published: (2016-12-01)

Tumor Atelectasis Gives Rise to a Solid Appearance in Pulmonary Adenocarcinomas on High-Resolution Computed Tomography
by: Francesca Ambrosi, MD, et al.
Published: (2020-06-01)

Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy
by: Maurice vanDuijvenvoorde, et al.
Published: (2022-01-01)